Piribo: Lymphoma: A Therapeutic & Competitive Insight

(PRLEAP.COM) Lymphoma is a broad term encompassing a variety of cancers of the lymphatic system. The two main groups of lymphoma in humans are Hodgkin’s disease (characterized by the growth of Reed-Sternberg cells) and the non-Hodgkin’s lymphoma (NHL). The world prevalence is approximately 650,000 cases, of which 300,000 are low grade and 350,000 are aggressive. The lymphoma market is a complex topic and several pitfalls await actors not well prepared. BioSeeker Group will guide thru this field and bring structure and knowledge enable our customers to analyze opportunities. This report will help to answer questions on the subject of additional lymphoma treatments beyond Rituxan.

Some of the drugs included in this analysis:
Aldesleukin , Apolizumab, Arsenic trioxide, Bevacizumab, BiovaxID , Bortezomib , CMC-544 , Enzastaurin , Epratuzumab, FavId , Flavopiridol, Genasense , IDEC-114 , Marqibo, MyVax, Nelarabine , Pixantrone , SGN-30, SGN-40 , Temsirolimus , Zanolimumab.

Some of the companies included in this analysis:
Accentia BioPharmaceuticals, Biogen , Cell Therapeutics , Cephalon , Chiron (now Novartis) Corporation , Eli Lilly , Favrille , Genentech , Genitope , Genmab , Genta , GlaxoSmithKline, Immunomedics , Inex Pharmaceuticals , Millennium Pharmaceuticals, Protein Design Labs , Roche, Sanofi-Aventis, Seattle Genetics , Wyeth.

“Lymphoma: A Therapeutic & Competitive Insight” is available in PDF format for immediate delivery from Piribo. For more information go to: <a href="http://www.piribo.com/search/results.html?k=BSK113&x=1&y=10"</a>Report Details</a>

Piribo Product ID: BSK113

About Piribo.
Piribo is a UK-based independent online store supplying business information on the pharmaceutical and biotechnology industries. The website now carries over 3,500 English language titles including, market reports, studies and books and is the UK’s largest online biopharma information store. Subscribers receive a free monthly newsletter and email alerts on new titles in their areas of interest. The company was established in 2004.

PR Leap is a service of Condesa, Inc. © 2009 All Rights Reserved. Use of our service is governed by our Privacy Policy and Terms of Service.
Issuers of news releases are solely responsible for the accuracy of their content. Copyright / IP Policy